123 related articles for article (PubMed ID: 12699747)
1. Synthesis and collateral dilator activity of nitroxyalkylamides having direct or latent sulfhydryl moieties.
Ishihara S; Saito F; Ohhata Y; Kanai M; Mizuno H; Fujisawa M; Yorikane R; Koike H
Bioorg Med Chem Lett; 2003 May; 13(9):1527-30. PubMed ID: 12699747
[TBL] [Abstract][Full Text] [Related]
2. NO donors, part 8 [1]: synthesis and vasodilating activities of substituted benzylnitrates compared to cyclohexylmethylnitrate and GTN.
Wessler C; Homann A; Fricke U; Lehmann J
Eur J Med Chem; 2003 Jun; 38(6):581-6. PubMed ID: 12832129
[TBL] [Abstract][Full Text] [Related]
3. Effects of nitrites on arterial collateral vessels of dogs.
Iriuchijima J
Jpn Heart J; 1971 Nov; 12(6):536-44. PubMed ID: 5003256
[No Abstract] [Full Text] [Related]
4. NO donors. Part 18: Bioactive metabolites of GTN and PETN--synthesis and vasorelaxant properties.
Lange K; Koenig A; Roegler C; Seeling A; Lehmann J
Bioorg Med Chem Lett; 2009 Jun; 19(11):3141-4. PubMed ID: 19406636
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of nitrate tolerance: a review.
Katz RJ
Cardiovasc Drugs Ther; 1990 Feb; 4(1):247-52. PubMed ID: 2126740
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the relation between collateral development and the effects of antianginal drugs--effects of nitroglycerin and 2-nicotinamidethyl nitrate on collateral circulation (author's transl)].
Inou T
Fukuoka Igaku Zasshi; 1981 Aug; 72(8):440-67. PubMed ID: 6457779
[No Abstract] [Full Text] [Related]
7. The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat.
França-Silva MS; Luciano MN; Ribeiro TP; Silva JS; Santos AF; França KC; Nakao LS; Athayde-Filho PF; Braga VA; Medeiros IA
Eur J Pharmacol; 2012 Sep; 690(1-3):170-5. PubMed ID: 22796675
[TBL] [Abstract][Full Text] [Related]
8. Novel organic nitrates are potent dilators of large coronary arteries with reduced development of tolerance during long-term infusion in dogs: role of the sulfhydryl moiety.
Zanzinger J; Feelisch M; Bassenge E
J Cardiovasc Pharmacol; 1994 May; 23(5):772-8. PubMed ID: 7521460
[TBL] [Abstract][Full Text] [Related]
9. [Recent findings on nitrates: their action, bioactivation and development of tolerance].
Münzel T
Dtsch Med Wochenschr; 2008 Oct; 133(44):2277-82. PubMed ID: 18946854
[TBL] [Abstract][Full Text] [Related]
10. Response of coronary microvascular collaterals to activation of ATP-sensitive K+ channels.
Lamping KG; Nuno DW; Brooks LA; Fujii M
Cardiovasc Res; 1997 Aug; 35(2):377-83. PubMed ID: 9349401
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409.
Isono T; Sato N; Yamamoto T; Sawada T; Yamazaki S; Miura S; Furuichi A; Ozaki R; Koibuchi Y; Ohtsuka M
Eur J Pharmacol; 1994 Aug; 260(2-3):163-8. PubMed ID: 7988640
[TBL] [Abstract][Full Text] [Related]
12. Development of insulin resistance by nitrate tolerance in conscious rabbits.
Bajza A; Peitl B; Nemeth J; Porszasz R; Rabloczky G; Literati-Nagy P; Szilvassy J; Szilvassy Z
J Cardiovasc Pharmacol; 2004 Mar; 43(3):471-6. PubMed ID: 15076233
[TBL] [Abstract][Full Text] [Related]
13. Influence of endothelium and nitrovasodilators on free thiols and disulfides in porcine coronary smooth muscle.
Kojda G; Meyer W; Noack E
Eur J Pharmacol; 1993 Dec; 250(3):385-94. PubMed ID: 8112399
[TBL] [Abstract][Full Text] [Related]
14. Arginine and nitrate tolerance.
MacAllister RJ
Br J Pharmacol; 2000 May; 130(2):209-10. PubMed ID: 10807656
[No Abstract] [Full Text] [Related]
15. Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo.
Mülsch A; Bara A; Mordvintcev P; Vanin A; Busse R
Br J Pharmacol; 1995 Nov; 116(6):2743-9. PubMed ID: 8590999
[TBL] [Abstract][Full Text] [Related]
16. Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels.
Boesgaard S; Aldershvile J; Poulsen HE; Loft S; Anderson ME; Meister A
Circ Res; 1994 Jan; 74(1):115-20. PubMed ID: 8261584
[TBL] [Abstract][Full Text] [Related]
17. (Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins.
Lazzarato L; Donnola M; Rolando B; Chegaev K; Marini E; Cena C; Di Stilo A; Fruttero R; Biondi S; Ongini E; Gasco A
J Med Chem; 2009 Aug; 52(16):5058-68. PubMed ID: 20560642
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide liberating, soluble guanylate cyclase stimulating and vasorelaxing properties of the new nitrate-compound SPM 3672.
Kojda G; Noack E
J Cardiovasc Pharmacol; 1993 Jul; 22(1):103-11. PubMed ID: 7690081
[TBL] [Abstract][Full Text] [Related]
19. Nitroglycerin dilates coronary collateral vessels during exercise after blockade of endogenous NO production.
Klassen CL; Traverse JH; Bache RJ
Am J Physiol; 1999 Sep; 277(3):H918-23. PubMed ID: 10484411
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide as a target for the hypotensive and vasorelaxing effects induced by (Z)-ethyl 12-nitrooxy-octadec-9-enoate in rats.
Machado NT; Maciel PM; Alustau MC; Queiroz TM; Furtado FF; Assis VL; Veras RC; Araújo IG; Athayde-Filho PF; Medeiros IA
Eur J Pharm Sci; 2014 Oct; 62():317-25. PubMed ID: 24964291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
